does blue cross blue shield cover glp-1 Drops Coverage of Obesity Drugs Blue Cross Blue Shield of
Description
2023, December 14
Currently, Saxenda (Liraglutide - NVO) and Wegovy (Semaglutide - NVO) are the two GLP-1 drugs approved for weight loss by the FDA
10.1016/j.clinme.2025.100298 Clin Med
Beyond facilitating weight loss, semaglutide also provides an array of additional health benefits: Enhanced cardiovascular health: It contributes to a reduced risk of heart disease and related cardiovascular issues
You obviously want to be tracking both your weight on the scale and your body measurements during use, but you can also track some lab tests
